90491 ⎘
Indexing scheme relating to specific properties of organic compounds Optical isomers
Direct, enantioselective aldol coupling of aldehydes using chiral organic catalysts
#2102(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereof
#2103Diamines having a CaSR modulating activity
#2104Method for the preparation of aryl ethers
#2105Pharmaceutical salts
#2106Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
#2107Process for preparing optically active 2,3-dihydrobenzofuran compounds
#2108Stereoselective alkylation of chiral 2-methyl-4-protected piperazines
#2109Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
#2110Compacted menthol
#2111Method of preparing amine stereoisomers
#2112Benzene derivatives and pharmaceutical use thereof
#2113Practical chiral zirconium catalyst
#2114Optically active compounds, method for kinetic optical resolution of carboxylic acid derivatives and catalysts therefor
#2115Method for the preparation of escitalopram
#2116Process for preparation of 2-aminotetralin derivatives and intermediates thereof
#2117Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof
#2118Carboxylic derivates
#2119Inhibitors of IMPDH enzyme
#2120Process for producing 2-aralkylpropionic acid derivative
#2121Process for producing optically active amino acid derivatives
#2122Method for making fluorine labeled L-Dopa
#2123Oxazoline ligands for asymmetric catalysis
#2124Amino acids with affinity for the alpha2delta-protein
#2125P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
#2126Process for chlorinating tertiary alcohols
#21273-substituted oxyglutaric diester compound, optically active 3-substituted oxyglutaric monoester compound, and processes for producing these
#21282-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
#2129Ligands for use in catalytic processes
#2130Resolution of 3-amino alkylnitriles
#2131Calcium receptor antagonists
#2132Indane acetic acid derivatives and their use as pharmaceutical agents
#2133Metallic catalysts for chemo-, regio- and stereoselective reactions, and corresponding precursors
#2134Method for preparing alkali and heat stable polyols
#2135Amino acids with affinity for the α2δ-protein
#2136Treatment of faecal incontinence and other conditions with 1r,2s-methoxamine
#2137Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
#2138Chiral copper complex and production processes thereof and using the same
#2139Recovery and recycling of chiral tartaric acid resolving agents
#2140Peptidomimetic ligands for cellular receptors and ion channels
#2141Process of preparing O-carbamoyl compounds in the presence of active amine group
#2142Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
#2143Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#2144Chiral diphosphorus compounds and their transition metal complexes
#2145Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy) ethyl) amino) propyl) -2-methoxybenzenesulfonamide
#2146Process for producing optically active ethyl (3R, 5S, 6E)-7-[2-cycloproply-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate
#2147Ammonium compounds bearing and electrophilic fluorine, reagent containing same, method using same and synthesis method for obtaining them
#2148Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
#2149Chiral compounds and compositions containing the same
#2150Process for the manufacture of HMG-CoA reductase inhibitors
#2151Process for producing optically active carboxylic acid
#2152Method for producing optically active beta-phenylalanine
#2153Method for producing optically active β-phenylalanine compounds
#2154Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
#2155Singlet oxygen catalysts including condensed carbon molecules
#2156Preparation of mono-N-sulphonylated diamines
#2157Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
#2158Enantiomerically selective cyclopropanation
#2159Enantiomerically enriched 2-butanol
#2160Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
#2161Process for preparing enantiomerically pure alpha phenyl-alpha (6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)-acetic acid derivatives
#2162Process
#2163Chiral ligands for asymmetric catalysis
#2164(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
#2165Preparation of chiral amino-nitriles
#2166S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride crystalline salt
#2167Process for producing crystal of benzenesulfonamide derivative, and novel crystal of intermediate therefor and process for producing the same
#2168Synthesis of isotopically labeled R- or S-[C, H] glycerols
#2169Polyamino acid-catalyzed process for the enantioselective epoxidation of α,β-unsaturated enones and α,β-unsaturated sulfones
#2170Process for producing benzoxazine derivative and production intermediate thereof
#2171Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical aggents comprising the same as active ingredient
#2172Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
#2173Method for preparing sulphostin and analogue thereof or preparation intermediate thereof
#2174C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
#2175Method for the production of dihydroxycarboxylate esters
#2176Compounds and a novel process for their preparation
#2177Process for the separation of R(-)-and S(+)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2- methoxybenzenesulfonamide
#2178Method of manufacturing cyano compounds
#2179Solid forms of enantiopure deuterium-enriched bupropion and methods of use thereof
#2180Method for synthesizing (S)-nicotine and intermediate thereof
#2181Substituted piperidines as BTK inhibitors
#2182Polycyclics as sigma receptor modulators
#2183HPK1 antagonists and uses thereof
#2184Process for preparing Brivaracetam
#2185Sulfoxide ligand metal catalyzed oxidation of olefins
#2186Process for the optical purification of esomeprazole
#2187Process for the preparation of linezolid
#2188Microencapsulated catalyst methods of preparation and method of use thereof